Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt Universität zu Berlin and Berlin Institute of Health iPATH Berlin Campus Benjamin Franklin Hindenburgdamm 30 12200 Berlin Germany

Department of Gastroenterology IBD Centre Humanitas Research Hospital Via A Manzoni 56 20089 Rozzano Milan Italy

Department of Gastroenterology Nancy University Hospital Vandoeuvre France and Inserm U1256 Lorraine University Vandoeuvre France

Department of Internal Medicine 1 Gastroenterology Hepatology Endocrinology and Metabolism Medical University Innsbruck Innsbruck Austria

Department of Pathology and Centre for Colorectal Disease St Vincent's University Hospital and University College Dublin Ireland

Department of Pathology GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands

Department of Pathology Karolinska Institute and University Hospital Stockholm Sweden

Department of Pathology Moffitt Cancer Center Tampa FL USA

Department of Pathology Radboud University Medical Centre Nijmegen The Netherlands

Department of Pathology Spedali Civili di Brescia Brescia Italy

Department of Pathology University of Michigan Ann Arbor MI USA

INNPATH Institute of Pathology Tirol Kliniken Innsbruck Austria and Patho im Zentrum St Pölten Austria

Institute for Legal Medicine Section Pathology University Hospital Jena Germany

Institute of Pathology Friedrich Alexander University Erlangen Germany

Institute of Pathology Klinikum Bayreuth GmbH Preuschwitzer Str 101 95445 Bayreuth Germany

Institute of Pathology University of Bern Bern Switzerland

Medical Clinic 1 Department of Medicine and Deutsches Zentrum Immuntherapie DZI University Hospital Friedrich Alexander University Erlangen Germany

Pathology and Data Analytics Leeds Institute of Medical Research at St James's University of Leeds Leeds UK

Pathology and Laboratory Medicine Mount Sinai Hospital University of Toronto Toronto ON Canada

Pathology Department Saint Antoine Hospital APHP Sorbonne University Paris France

The Fingerland Department of Pathology Faculty of Medicine and University Hospital Charles University Hradec Králové Czech Republic

The Transregio 241 IBDome Consortium Erlangen Germany

See more in PubMed

GBD 2017 Inflammatory Bowel Disease Collaborators The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30. doi: 10.1016/S2468-1253(19)30333-4. PubMed DOI PMC

Kucharzik A, Dignass AU, Atreya R, et al. Updated S3-Guideline colitis ulcerosa. German Society for Digestive and Metabolic Diseases (DGVS) - AWMF Registry 021/009. Z Gastroenterol. 2018;56:1087–1169. doi: 10.1055/a-0651-8174. PubMed DOI

Allison MC, Hamilton-Dutoit SJ, Dhillon AP, et al. The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med. 1987;65:985–995. PubMed

Bentley E, Jenkins D, Campbell F, Warren B. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol. 2002;55:955–960. doi: 10.1136/jcp.55.12.955. PubMed DOI PMC

Dejaco C, Oesterreicher C, Angelberger S, Püspök A, Birner P, Poetzi R, Gangl A, Oberhuber G. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy. 2003;35:1004–1008. doi: 10.1055/s-2003-44593. PubMed DOI

Dube AK, Cross SS, Lobo AJ. Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease. J Clin Pathol. 1998;51:378–381. doi: 10.1136/jcp.51.5.378. PubMed DOI PMC

Dundas SA, Dutton J, Skipworth P. Reliability of rectal biopsy in distinguishing between chronic inflammatory bowel disease and acute self-limiting colitis. Histopathology. 1997;31:60–66. doi: 10.1046/j.1365-2559.1997.5810818.x. PubMed DOI

Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Shepherd NA, Theodossi A, Williams GT. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol. 1997;50:93–105. doi: 10.1136/jcp.50.2.93. PubMed DOI PMC

Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology. 1987;92:318–328. doi: 10.1016/0016-5085(87)90124-7. PubMed DOI

Schumacher G, Kollberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol. 1994;29:318–332. doi: 10.3109/00365529309098313. PubMed DOI

Seldenrijk CA, Morson BC, Meuwissen SG, Schipper NW, Lindeman J, Meijer CJ. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut. 1991;32:1514–1520. doi: 10.1136/gut.32.12.1514. PubMed DOI PMC

Surawicz CM, Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology. 1984;86:104–113. doi: 10.1016/0016-5085(84)90595-X. PubMed DOI

Tanaka M, Masuda T, Yao T, Saito H, Kusumi T, Nagura H, Kudo H. Observer variation of diagnoses based on simple biopsy criteria differentiating among Crohnʼs disease, ulcerative colitis, and other forms of colitis. J Gastroenterol Hepatol. 2001;16:1368–1372. doi: 10.1046/j.1440-1746.2001.02638.x. PubMed DOI

Tanaka M, Riddell RH, Saito H, Soma Y, Hidaka H, Kudo H. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohnʼs disease from ulcerative colitis. Scand J Gastroenterol. 1999;34:55–67. doi: 10.1080/00365529950172844. PubMed DOI

Tanaka M, Saito H, Fukuda S, Sasaki Y, Munakata A, Kudo H. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity. Scand J Gastroenterol. 2000;35:281–286. doi: 10.1080/003655200750024155. PubMed DOI

Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, Leader M, Levison DA, Lindley R, Filipe I, Price A. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut. 1994;35:961–968. doi: 10.1136/gut.35.7.961. PubMed DOI PMC

Langner C, Magro F, Driessen A, Ensari A, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R, Geboes K. The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch. 2014;464(5):511–527. doi: 10.1007/s00428-014-1543-4. PubMed DOI

Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113:481–517. doi: 10.1038/ajg.2018.27. PubMed DOI

Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413. doi: 10.14309/ajg.0000000000000152. PubMed DOI

Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174–178. doi: 10.1136/gut.32.2.174. PubMed DOI PMC

Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, Ransil B, Wild G, Cohen A, Deb Edwardes MD, Stevens AC. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13–20. doi: 10.1053/gast.2001.20912. PubMed DOI

Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619–1635. doi: 10.1136/gutjnl-2012-302830. PubMed DOI

Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J. 1956;1:1315–1318. doi: 10.1136/bmj.1.4979.1315. PubMed DOI PMC

Frøslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412–422. doi: 10.1053/j.gastro.2007.05.051. PubMed DOI

Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194–1201. doi: 10.1053/j.gastro.2011.06.054. PubMed DOI

Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJS, Present D, Sands BE, Colombel JF. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137:1250–1260. doi: 10.1053/j.gastro.2009.06.061. PubMed DOI

Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, Bala M, Johanns J, Olson A, Hanauer SB. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol. 2007;102:794–802. doi: 10.1111/j.1572-0241.2007.01094.x. PubMed DOI

Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, DʼHaens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV, Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, van Assche G, Danese S, Panes J, Bouguen G, OʼDonnell S, Pariente B, Winer S, Hanauer S, Colombel JF. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–1328. doi: 10.1038/ajg.2015.233. PubMed DOI

Bessissow T, Lemmens B, Ferrante M, Bisschops R, van Steen K, Geboes K, van Assche G, Vermeire S, Rutgeerts P, de Hertogh G. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol. 2012;107:1684–1692. doi: 10.1038/ajg.2012.301. PubMed DOI

Park S, Abdi T, Gentry M, Laine L. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2016;111:1692–1701. doi: 10.1038/ajg.2016.418. PubMed DOI

Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun–Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013;11:1601–1608. doi: 10.1016/j.cgh.2013.06.023. PubMed DOI PMC

Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–1105. doi: 10.1053/j.gastro.2007.08.001. PubMed DOI PMC

Hefti MM, Chessin DB, Harpaz NH, Steinhagen RM, Ullman TA. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum. 2009;52:193–197. doi: 10.1007/DCR.0b013e31819ad456. PubMed DOI PMC

Bryant RV, Burger DC, Delo J, Walsh AJ, Thomas S, von Herbay A, Buchel OC, White L, Brain O, Keshav S, Warren BF, Travis SPL. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut. 2016;65(3):408–414. doi: 10.1136/gutjnl-2015-309598. PubMed DOI

Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol. 2014;12:929–934. doi: 10.1016/j.cgh.2013.07.022. PubMed DOI

Feagins LA, Melton SD, Iqbal R, Dunbar KB, Spechler SJ. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis. 2013;18:1477–1482. doi: 10.1097/MIB.0b013e318281f4ae. PubMed DOI

Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, Hart J, Rubin DT. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol. 2017;15:1557–1564. doi: 10.1016/j.cgh.2017.02.016. PubMed DOI PMC

Food and Drug Administration. Ulcerative colitis: clinical trial endpoints guidance for industry. Draft Guidance. Silver Spring, MD: FDA; p. 19. Report No.: 15028dft.doc 07/27/16 UCM515143. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-clinical-trial-endpoints-guidance-industry.

Novak G, Parker CE, Pai RK, MacDonald JK, Feagan BG, Sandborn WJ, D’Haens G, Jairath V, Khanna R. Histologic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database Syst Rev. 2017;7:CD012351. doi: 10.1002/14651858.CD012351.pub2. PubMed DOI PMC

Mosli MH, Parker CE, Nelson SA, et al. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev. 2017;5:CD011256. doi: 10.1002/14651858.CD011256.pub2. PubMed DOI PMC

Magro F, Doherty G, Peyrin-Biroulet L, et al. ECCO position paper: harmonization of the approach to ulcerative colitis histopathology. J Crohns Colitis. 2020;14(11):1503–1511. doi: 10.1093/ecco-jcc/jjaa110. PubMed DOI

Likert R. A technique for the measurement of attitudes. In: Archives of Psychology. 1932;22(140):55.

Gomollón F, Dignass A, Annese V, Tilg H, van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F, Almer S, Armuzzi A, Harbord M, Langhorst J, Sans M, Chowers Y, Fiorino G, Juillerat P, Mantzaris GJ, Rizzello F, Vavricka S, Gionchetti P, on behalf of ECCO 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3–25. doi: 10.1093/ecco-jcc/jjw168. PubMed DOI

Feakins RM. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013;66:1–22. doi: 10.1136/jclinpath-2013-201885. PubMed DOI

Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW, Kupcinskas L, Lakatos PL, Mantzaris GJ, Schreiber S, Villanacci V, Warren BF, European Crohn's and Colitis Organisation (ECCO) European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis. 2008;2:1–23. doi: 10.1016/j.crohns.2007.11.001. PubMed DOI

Stange EF, Travis SPL, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, Barakauskiene A, Villanacci V, von Herbay A, Warren BF, Gasche C, Tilg H, Schreiber SW, Schölmerich J, Reinisch W, European Crohn's and Colitis Organisation European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut. 2006;55(suppl 1):1–15. doi: 10.1136/gut.2005.081950a. PubMed DOI PMC

Bernstein C, Eliakim A, Fedail S, Fried M, Gearry R, Goh KL, Hamid S, Khan AG, Khalif I, Ng SC, Ouyang Q, Rey JF, Sood A, Steinwurz F, Watermeyer G, LeMair A, Review Team World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: update August 2015. J Clin Gastroenterol. 2015;50(10):803–818. doi: 10.1097/MCG.0000000000000660. PubMed DOI

Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R, European Society of Pathology (ESP) European Crohn's and Colitis Organisation (ECCO) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827–851. doi: 10.1016/j.crohns.2013.06.001. PubMed DOI

Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1: definitions and diagnosis. J Crohns Colitis. 2012;6(10):965–990. doi: 10.1016/j.crohns.2012.09.003. PubMed DOI

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B’H, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, IBD guidelines eDelphi consensus group. Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106. doi: 10.1136/gutjnl-2019-318484. PubMed DOI PMC

Sharaf RN, Shergill AK, Odze RD, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–224. doi: 10.1016/j.gie.2013.04.167. PubMed DOI

OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=565.

Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Götz M, Katsanos KH, Kießlich R, Ordás I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R, European Crohn's and Colitis Organisation European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7:982–1018. doi: 10.1016/j.crohns.2013.09.016. PubMed DOI

Carter MJ, Lobo AJ, Travis SP. IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(Suppl 5):1–16. doi: 10.1136/gut.2004.043372. PubMed DOI PMC

Feakins RM, Campbell F, Mears L, et al. Tissue pathways for gastrointestinal and hepatopancreatobiliary pathology. London: Royal College of Pathologists; 2009.

Carbonnel F, Lavergne A, Lemann M, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci. 1994;39:1550–1557. doi: 10.1007/BF02088063. PubMed DOI

Washington K, Greenson JK, Montgomery E, Shyr Y, Crissinger KD, Polk DB, Barnard J, Lauwers GY. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol. 2002;26:1441–1449. doi: 10.1097/00000478-200211000-00006. PubMed DOI

Coremans G, Rutgeerts P, Geboes K, van den Oord J, Ponette E, Vantrappen G. The value of ileoscopy with biopsy in the diagnosis of intestinal Crohn’s disease. Gastrointest Endosc. 1984;30:167–172. doi: 10.1016/s0016-5107(84)72358-3. PubMed DOI

Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol. 1991;86:187–190. PubMed

Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol. 1998;22:983–989. doi: 10.1097/00000478-199808000-00008. PubMed DOI

Mutinga ML, Odze RD, Wang HH, Hornick JL, Farraye FA. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis. 2004;10:215–219. doi: 10.1097/00054725-200405000-00006. PubMed DOI

Scott IS, Sheaff M, Coumbe A, Feakins RM, Rampton DS. Appendiceal inflammation in ulcerative colitis. Histopathology. 1998;33:168–173. doi: 10.1046/j.1365-2559.1998.00477.x. PubMed DOI

Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol. 2003;16:347–358. doi: 10.1097/01.MP.0000064746.82024.D1. PubMed DOI

D’Haens G, Geboes K, Peeters M, et al. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol. 1997;92:1275–1279. PubMed

Kroft SH, Stryker SJ, Rao MS. Appendiceal involvement as a skip lesion in ulcerative colitis. Mod Pathol. 1994;7:912–914. PubMed

Bernstein CN, Shanahan F, Anton PA, Weinstein WM. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc. 1995;42:232–237. doi: 10.1016/s0016-5107(95)70097-8. PubMed DOI

Geboes K. Pathology of inflammatory bowel diseases (IBD): variability with time and treatment. Color Dis. 2001;3:2–12. doi: 10.1046/j.1463-1318.2001.00187.x. PubMed DOI

Markowitz J, Kahn E, Grancher K, Hyams J, Treem W, Daum F. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol. 1993;88:2034–2037. PubMed

Robert ME, Tang L, Hao LM, Reyes-Mugica M. Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10 years. Am J Surg Pathol. 2004;28:183–189. doi: 10.1097/00000478-200402000-00005. PubMed DOI

Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn’s disease. Hepatogastroenterology. 1990;37:18–31. PubMed

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ, Cochrane IBD Group Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2010;20:CD004115. doi: 10.1002/14651858.CD004115.pub2. PubMed DOI

Lie MR, Kanis SL, Hansen BE, et al. Drug therapies for ulcerative proctitis: systematic review and meta-analysis. Inflamm Bowel Dis. 2014;20:2157–2178. doi: 10.1097/MIB.0000000000000141. PubMed DOI

Cohen RD, Dalal SR. Systematic review: Rectal therapies for the treatment of distal forms of ulcerative colitis. Inflamm Bowel Dis. 2015;21:1719–1736. doi: 10.1097/MIB.0000000000000379. PubMed DOI

Geboes K, Dalle I. Influence of treatment on morphological features of mucosal inflammation. Gut. 2002;50:iii37–iii42. doi: 10.1136/gut.50.suppl_3.iii37. PubMed DOI PMC

Mosli MH, Feagan BG, Sandborn WJ, DʼHaens G, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, MacDonald JK, Vandervoort MK, Geboes K, Levesque BG. Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices. Inflamm Bowel Dis. 2014;20(3):564–575. doi: 10.1097/01.MIB.0000437986.00190.71. PubMed DOI

Odze R, Antonioli D, Peppercorn M, Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol. 1993;27:869–875. doi: 10.1097/00000478-199309000-00002. PubMed DOI

Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 2012;5(4):354–366. doi: 10.1038/mi.2012.24. PubMed DOI

Billioud V, Ford AC, Del Tedesco E, et al. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohn Colitis. 2013;7(11):853–867. doi: 10.1016/j.crohns.2013.01.014. PubMed DOI

Herfarth H, Tjaden C, Lukas M, et al. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn’s disease. Gut. 2006;55(10):1525–1526. PubMed PMC

D’Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology. 2008;135(4):1123–1129. doi: 10.1053/j.gastro.2008.07.010. PubMed DOI

Nos P, Hinojosa J, Aguilera V, Moles JR, et al. Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn’s disease. Gastroenterol Hepatol. 2000;23(8):374–378. PubMed

Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, on behalf of the International AZT-2 Study Group Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn’s disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut. 2010;59(6):752–759. doi: 10.1136/gut.2009.194159. PubMed DOI

Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol. 2009;104(8):2089–2096. doi: 10.1038/ajg.2009.301. PubMed DOI

Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136(2):441–450. doi: 10.1053/j.gastro.2008.10.051. PubMed DOI

Regueiro M, Baidoo L, Kip KE, et al. Infliximab maintenance beyond one year prevents postoperative Crohn’s disease recurrence: long-term follow-up from the randomized controlled pilot study. Gastroenterology. 2013;144(5):S173–S17S. doi: 10.1016/S0016-5085(13)60618-6. DOI

Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Yokoyama Y, Iimuro M, Takeda N, Kato K, Kikuyama R, Nagase K, Hori K, Nakamura S, Miwa H, Matsumoto T. Scheduled infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. Inflamm Bowel Dis. 2012;18(9):1617–1623. doi: 10.1002/ibd.21928. PubMed DOI

Lin J, McKenna BJ, Appelman HD. Morphologic findings in upper gastrointestinal biopsies of patients with ulcerative colitis: a controlled study. Am J Surg Pathol. 2010;34:1672–1677. doi: 10.1097/PAS.0b013e3181f3de93. PubMed DOI

Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, Walker-Smith JA, Thomson M. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2004;39(3):257–261. doi: 10.1097/00005176-200409000-00006. PubMed DOI

Greuter T, Piller A, Fournier N, et al. Upper gastrointestinal tract involvement in Crohn’s disease: frequency, risk factors, and disease course. J Crohns Colitis. 2018;12(12):1399–1409. doi: 10.1093/ecco-jcc/jjy121. PubMed DOI

Oberhuber G, Püspök A, Oesterreicher C, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease. Gastroenterology. 1997;112(3):698–706. doi: 10.1053/gast.1997.v112.pm9041230. PubMed DOI

Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn’s disease. Am J Surg Pathol. 1998;22(4):383–390. doi: 10.1097/00000478-199804000-00001. PubMed DOI

Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794. doi: 10.1053/j.gastro.2011.01.055. PubMed DOI

Levine DS, Haggitt RC. Normal histology of the colon. Am J Surg Pathol. 1989;13:966–984. doi: 10.1097/00000478-198911000-00008. PubMed DOI

Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. doi: 10.1053/j.gastro.2011.10.001. PubMed DOI

Burisch J, Pedersen N, Cukovic-Cavka S, et al. East–west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63:588–597. doi: 10.1136/gutjnl-2013-304636. PubMed DOI

Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Laszlo Lakatos P. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006. Inflamm Bowel Dis. 2011;17:2558–2265. doi: 10.1002/ibd.21607. PubMed DOI

Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD) Gut. 1996;39:690–697. doi: 10.1136/gut.39.5.690. PubMed DOI PMC

Björnsson S, Jóhannsson JH. Inflammatory bowel disease in Iceland, 1990–1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol. 2000;12:31–38. doi: 10.1080/00365529850166239. PubMed DOI

Vind L, Riis T, Jess E, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282. doi: 10.1111/j.1572-0241.2006.00552.x. PubMed DOI

Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol. 1991;26:1247–1256. doi: 10.3109/00365529108998621. PubMed DOI

Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Sauar J, Schulz T, Stray N. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:362–366. doi: 10.3109/00365529609006411. PubMed DOI

Geboes K, Colombel JF, Greenstein A, Jewell DP, Sandborn WJ, Vatn MH, Warren B, Riddell RH, Pathology Task Force of the International Organization of Inflammatory Bowel Diseases Indeterminate colitis: a review of the concept – what’s in a name? Inflamm Bowel Dis. 2008;14:850–857. doi: 10.1002/ibd.20361. PubMed DOI

Bonetti LR, Manta R, Manno M, et al. Optimal processing of ESD specimens to avoid pathological artifacts. Tech Coloproctol. 2018;22:857–866. doi: 10.1007/s10151-018-1887-x. PubMed DOI

Kim B, Barnett JL, Kleer CG, Appelman HD. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol. 1999;94:3258–3262. doi: 10.1111/j.1572-0241.1999.01533.x. PubMed DOI

Gramlich T, Petras RE. Pathology of inflammatory bowel disease. Semin Pediatr Surg. 2007;16:154–163. doi: 10.1053/j.sempedsurg.2007.04.005. PubMed DOI

Pai RK, Jairath V, Vande Casteele N, Rieder F, Parker CE, Lauwers GY. The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointest Endosc. 2018;88:887–898. doi: 10.1016/j.gie.2018.08.018. PubMed DOI

Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, MacDonald JK, Vandervoort MK, Samaan MA, Geboes K, Valasek MA, Pai R, Langner C, Riddell R, Harpaz N, Sewitch M, Peterson M, Stitt LW, Levesque BG. Reproducibility of histological assessment of disease activity in UC. Gut. 2014;64:1–9. doi: 10.1136/gutjnl-2014-307536. PubMed DOI

Surawicz CM, Haggitt RC, Husseman M, McFarland LV. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology. 1994;107:755–763. doi: 10.1016/0016-5085(94)90124-4. PubMed DOI

Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, Diebold MD, Danese S, Reinisch W, Schreiber S, Travis S, Peyrin-Biroulet L. Development and validation of the Nancy histological index for UC. Gut. 2017;66:43–49. doi: 10.1136/gutjnl-2015-310187. PubMed DOI

Rubio CA, Johansson C, Uribe A, Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission. Scand J Gastroenterol. 1984;19:525–530. doi: 10.1080/00365521.1984.12005764. PubMed DOI

Sadik CD, Kim ND, Luster AD. Neutrophils cascading their way to inflammation. Trends Immunol. 2011;32:452–460. doi: 10.1016/j.it.2011.06.008. PubMed DOI PMC

Chin AC, Parkos CA. Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu Rev Pathol. 2007;2:111–143. doi: 10.1146/annurev.pathol.2.010506.091944. PubMed DOI

Pai RK, Hartman DJ, Rivers CR, Regueiro M, Schwartz M, Binion DG, Pai RK. Complete resolution of mucosal neutrophils associates with improved long-term clinical outcomes of patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2019;18(11):2510–2517. doi: 10.1016/j.cgh.2019.12.011. PubMed DOI

Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Shackelton LM, Walker CW, Nelson S, Vandervoort MK, Frisbie V, Samaan MA, Jairath V, Driman DK, Geboes K, Valasek MA, Pai RK, Lauwers GY, Riddell R, Stitt LW, Levesque BG. Development and validation of a histological index for UC. Gut. 2017;66:50–58. doi: 10.1136/gutjnl-2015-310393. PubMed DOI

Bressenot A, Salleron J, Bastien C, Danese S, Boulagnon-Rombi C, Peyrin-Biroulet L. Comparing histological activity indexes in UC. Gut. 2015;64(9):1412–1418. doi: 10.1136/gutjnl-2014-307477. PubMed DOI

Feagan BG, Greenberg GR, Wild G, Fedorak RN, Paré P, McDonald JWD, Dubé R, Cohen A, Steinhart AH, Landau S, Aguzzi RA, Fox IH, Vandervoort MK. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. New Engl J Med. 2005;352(4):2499–2507. doi: 10.1056/NEJMoa042982. PubMed DOI

Targan SR, Karp LC. Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach. Curr Opin Gastroenterol. 2007;23:390–394. doi: 10.1097/MOG.0b013e3281722271. PubMed DOI

Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol. 2010;45:571–583. doi: 10.1007/s00535-010-0219-3. PubMed DOI

Ng SC, Kamm MA. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis. 2009;15:935–950. doi: 10.1002/ibd.20797. PubMed DOI

Christensen B, Erlich J, Gibson PR, Turner JR, Hart J, Rubin DT. Histologic healing is more strongly associated with clinical outcomes in ileal Crohn’s disease than endoscopic healing. Clin Gastroenterol Hepatol. 2020;18:2518–2525. doi: 10.1016/jcgh.2020.01.032. PubMed DOI PMC

The Number of Colon Crypts in Digital Mucosal Samples: A New Independent Parameter for Diagnosing Ulcerative Colitis

Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?

Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s Disease